The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alstrom syndrome: phase 3 trial design
The rest received the same lifestyle counseling and a placebo jab
[DOI] [PMC free article] [PubMed] [Google Scholar] [182].Vandeplas S, Dubois Dauphin R, Beckers Y, Thonart P, Thewis A
[DOI] [PubMed] [Google Scholar] 15.Bolinder J., Ljunggren O., Kullberg J., et al
The broader receptor profile of these newer-generation GLP-1 receptor agonists is thought to offer clinical advantages, potentially providing better tolerability or enhanced effectiveness due to simultaneous modulation of reward-related neural circuits and metabolic pathways (Ray 2023
The smartest first step is a medical evaluation to confirm its true glandular tissue (not just excess fat), review likely triggers like hormonal imbalances, certain medications, or anabolic steroids, and decide whether watchful waiting, medical treatment, or male breast reduction makes sense